The AlphaGroup of scientific and medical communications agencies is pleased to announce the 15-year anniversary of AlphaBioCom, established in 2005 by founding partners Stephen Douthwaite and Ed Shifflett, PhD. AlphaBioCom is renowned for delivering an industry-best, comprehensive scientific communications for the pharmaceutical, biotech, and medical device/diagnostic industries. In conjunction with this milestone, the AlphaGroup is launching AlphaScientia and AlphaQsci to deliver the most comprehensive and highest-quality scientific, medical affairs, and outcomes communication services worldwide.
“AlphaGroup is built on three pillars of success—Precision, Integrity, and Passion,” Douthwaite said. “Our goal is to cultivate a culture of quality, caring, cutting-edge thinking, and service across a team that is reinventing the medical and scientific communications industry standard globally.”
Over 15 years, AlphaBioCom has earned a reputation for creating superior, comprehensive scientific communications. The agency’s services include Strategic Planning and Support, Publications Planning and Execution, Market Access and Health Economics Communication, Internal Communications and Training, Clinical Trial Support, Creative and Digital Design, Scientific Event Management, Digital Communications and Social Media Networks, External Expert Engagement, and Congress Support.
“The launch of AlphaScientia and AlphaQsci further establishes AlphaGroup’s leadership role in providing the most advanced, evidence-based communications for the medical affairs and scientific research industries,” Shifflett said.
The objective for AlphaScientia is to offer premium medical communications with the finest scientific and client services staffs. AlphaScientia creates and delivers materials of enduring value using superior design and technical content allied with cutting-edge strategic and tactical planning.
AlphaQsci is positioned as a cutting-edge medical outcomes and HEOR communications agency. By staffing the agency with outcomes experts, AlphaQsci can boast an industry-leading team that focuses specifically on clinical, health outcomes, and quality of life outcome communications. AlphaQsci is setting a new standard for quality and services in this sector.
AlphaGroup’s first pillar of excellence is Precision. This describes the company’s dedication to recruiting, training, retaining, and celebrating the very best scientific medical writers and designers, account staff, and operations teams to deliver the top-of-the-line communication services in the industry.
The company’s emphasis on Integrity recognizes that each employee is essential for a corporate culture that operates transparently to ensure mutual trust and to inspire collaboration. AlphaGroup fosters an environment of individual expression and professional ambition, embracing diversity across all aspects of humanity for a universal oneness.
The third pillar, Passion, is AlphaGroup’s deeply rooted belief that their work is essential to the practice of medicine, and that medical diagnoses and treatment decisions are predicated on the information that healthcare providers receive. AlphaGroup’s agencies discern that precision in healthcare communications is paramount, and this vigor is evidenced in their focus on individuals, community, and organizational evolution.
“We endeavor to make the work life of our prestigious clients more productive, efficient, and enjoyable by optimizing, integrating, and harmonizing data with a robust offering of communication vehicles, technical expertise, and creative rigor,” Douthwaite said.
About AlphaGroup Medical Communications:
The AlphaGroup is a team of scientific and medical affairs communication specialists supporting AlphaBioCom, AlphaScientia, and AlphaQsci agencies. The company is made up of PhD scientists, MDs, PharmDs, nurses, designers, and communication and innovation experts. Their collective genius delivers the highest-quality scientific, medical affairs, and outcomes communication services anywhere in the world.
To learn more about AlphaGroup, follow them on LinkedIn, Facebook, Twitter, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200728005271/en/